1. Home
  2. ABUS vs HNRG Comparison

ABUS vs HNRG Comparison

Compare ABUS & HNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbutus Biopharma Corporation

ABUS

Arbutus Biopharma Corporation

HOLD

Current Price

$4.13

Market Cap

929.6M

Sector

Health Care

ML Signal

HOLD

HNRG

Hallador Energy Company

HOLD

Current Price

$15.84

Market Cap

790.0M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABUS
HNRG
Founded
2005
1949
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Coal Mining
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
929.6M
790.0M
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
ABUS
HNRG
Price
$4.13
$15.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.00
$25.38
AVG Volume (30 Days)
1.6M
954.1K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
55.26
116.78
EPS
N/A
0.96
Revenue
$14,083,000.00
$469,466,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$239.71
$12.12
P/E Ratio
N/A
$16.54
Revenue Growth
128.21
16.09
52 Week Low
$3.04
$13.60
52 Week High
$5.10
$24.70

Technical Indicators

Market Signals
Indicator
ABUS
HNRG
Relative Strength Index (RSI) 40.44 46.02
Support Level $3.41 $14.94
Resistance Level $4.71 $17.12
Average True Range (ATR) 0.20 0.82
MACD -0.03 0.13
Stochastic Oscillator 13.57 54.48

Price Performance

Historical Comparison
ABUS
HNRG

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes imdusiran (AB-729), a GalNAc-conjugated, subcutaneously delivered ribonucleic acid interference (RNAi) therapeutic, and AB-101, its proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

About HNRG Hallador Energy Company

Hallador Energy Co is a vertically integrated, independent power producer (IPP) and fuel company with operations in Indiana. The Company operates across multiple stages of the energy value chain, from accredited capacity and energy to coal. The Company's electric operations are located within the Midcontinent Independent System Operator's (MISO) footprint. The company's business is organized based on the services and products it provide in two segments: (i) Electric Operations and (ii) Coal Operations.

Share on Social Networks: